Cigna (CI)
Combines pharmacy benefits and specialty care services with employer and international health coverage.
$270.33
vs last close−3.41 (−1.25%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 49,048 | 51,114 | 57,255 | 60,523 | 63,694 | 65,649 | 65,502 | 67,230 | 69,748 | 72,472 | 68,494 | 71,668 |
| Cost of revenue | 42,566 | 44,541 | 50,871 | 54,007 | 57,092 | 59,187 | 58,896 | 59,344 | 63,808 | 66,918 | 62,024 | 56,703 |
| Gross profit | 6,482 | 6,573 | 6,384 | 6,516 | 6,602 | 6,462 | 6,606 | 7,886 | 5,940 | 5,554 | 6,470 | 14,965 |
| 4,242 | 4,513 | 4,128 | 4,104 | 4,026 | 4,289 | 4,635 | 5,454 | 3,362 | 3,406 | 4,112 | 12,289 | |
| 3,585 | 3,750 | 3,668 | 3,628 | 3,522 | 3,743 | 3,799 | 3,433 | 3,362 | 3,406 | 3,722 | 3,470 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,722 | 0 |
| Other expenses | 657 | 763 | 460 | 476 | 504 | 546 | 836 | 2,021 | 0 | 0 | 390 | 8,819 |
| Operating income | 2,240 | 2,060 | 2,256 | 2,412 | 2,576 | 2,173 | 1,971 | 2,432 | 2,578 | 2,148 | 2,358 | 2,676 |
| −400 | −1,872 | −2,177 | −423 | −1,384 | −164 | −323 | −411 | −283 | −519 | −88 | −419 | |
| Interest expense | 365 | 360 | 322 | 375 | 376 | 362 | 362 | 337 | 347 | 335 | 357 | 356 |
| Other non-operating income | −203 | −312 | −37 | −56 | −68 | −122 | −414 | 74 | −64 | 184 | −269 | 63 |
| Income before tax | 1,840 | 188 | 79 | 1,989 | 1,192 | 2,009 | 1,648 | 2,021 | 2,295 | 1,629 | 2,270 | 2,257 |
| Income tax expense | 391 | −919 | 291 | 360 | 367 | 473 | 239 | 389 | 322 | 395 | 409 | 382 |
| Net income from continuing operations | 1,449 | 1,107 | −212 | 1,629 | 825 | 1,536 | 1,409 | 1,632 | 1,973 | 1,234 | 1,861 | 1,875 |
| Net income | 1,408 | 1,029 | −277 | 1,548 | 739 | 1,424 | 1,323 | 1,532 | 1,868 | 1,234 | 1,654 | 1,660 |
| EPS, basic | $4.79 | $3.49 | −$0.97 | $5.51 | $2.65 | $5.13 | $4.88 | $5.76 | $7.02 | $4.64 | $6.30 | $6.29 |
| EPS, diluted | $4.74 | $3.49 | −$0.97 | $5.45 | $2.63 | $5.13 | $4.85 | $5.71 | $6.97 | $4.64 | $6.26 | $6.29 |
| Weighted average shares, basic | 294 | 295 | 286 | 281 | 278 | 278 | 280 | 266 | 266 | 266 | 263 | 264 |
| Weighted average shares, diluted | 297 | 295 | 286 | 284 | 281 | 278 | 283 | 268 | 268 | 266 | 264 | 264 |
| EBITDA | 3,209 | 3,137 | 3,034 | 3,206 | 3,294 | 2,941 | 3,059 | 3,040 | 3,339 | 2,544 | 3,277 | 2,613 |
| Depreciation & amortization | 766 | 765 | 741 | 738 | 650 | 646 | 674 | 682 | 697 | 580 | 650 | 0 |
| EBIT | 2,443 | 2,372 | 2,293 | 2,468 | 2,644 | 2,295 | 2,385 | 2,358 | 2,642 | 1,964 | 2,627 | 2,613 |